摘要
背景:放射疗法是普通和晚期肺癌患者最广泛使用的治疗方法。此外,放射治疗引起的临床毒性分为急性放射性肺炎和晚期肺纤维化。上皮 - 间质转化(EMT)是一个复杂的生理过程,涉及许多信号分子和蛋白质,如衔接蛋白和转录因子。它被确定为纤维化,伤口愈合和癌症的重要机制。辐射诱导的肺部EMT中出现了多种生物标志物,其中一些是获得性的(N-钙粘蛋白,波形蛋白和纤维连接蛋白等),其中一些在上皮细胞转变过程中被抑制(E-钙粘蛋白,zona occludens- 1)。 目的:在目前的综述中,我们强调了辐射诱导的肺EMT信号通路及其介质。我们还讨论了癌症,纤维化及其表观的EMT。 结果:辐射诱导的肺EMT受MAPK,NF-κB,Wnt,microRNA和组蛋白修饰等多种信号通路控制。转录因子如Snail,slug,twist,ZEB1(Zinc finger E-box binding-1)和ZEB2(Zinc finger E-box binding-2)蛋白是连接辐射诱导的EMT和纤维化的诱导物。表观遗传调节是基因组结构和功能的可遗传变化,其发生时序列没有任何变化。几种方法显示了表观遗传修饰及其抑制剂在控制纤维化和癌症中的作用。只有有限的报告集中于了解辐射诱导的肺部EMT的表观遗传调节。 结论:目前的综述重点关注辐射诱导的肺纤维化和EMT的最新发现,从而提供了重要信号通路的一些信息,其随后表达的基因和参与EMT的蛋白质。该综述还讨论了可用于治疗EMT相关疾病,即纤维化,癌症的各种抑制剂。
关键词: 辐射,EMT,表观遗传学,抑制剂,纤维化,信号通路。
图形摘要
Current Drug Targets
Title:Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators
Volume: 19 Issue: 10
关键词: 辐射,EMT,表观遗传学,抑制剂,纤维化,信号通路。
摘要: Background: Radiotherapy is the most widely used treatment method for average and advanced lung cancer patients. Moreover, the clinical toxicities caused by radiotherapy are categorized into acute radiation pneumonitis and late pulmonary fibrosis. Epithelial-mesenchymal transition (EMT) is a complex physiological process involves many signaling molecules and proteins like adaptor proteins, and transcriptional factors. It was identified as a significant mechanism for fibrosis, wound healing and also cancer. A variety of biomarkers have appeared in radiation-induced lung EMT, some of which are acquired (N-cadherin, vimentin and fibronectin, etc.) and some of which are repressed during the transition of epithelial cells (E-cadherin, zona occludens-1).
Objective: In the current review, we highlighted the radiation-induced lung EMT signaling pathway and their mediators. We also discuss the EMT in cancer, fibrosis and its epigentics.
Results: Radiation-induced lung EMT is controlled by numerous signaling pathways like MAPK, NF- κB, Wnt, microRNAs and histone modifications. Transcriptional factors such as Snail, slug, twist, ZEB1 (Zinc finger E-box binding-1) and ZEB2 (Zinc finger E-box binding-2) proteins are inducers linking radiation-induced EMT and fibrosis. Epigenetic modulations are heritable changes in the structure and function of the genome that occurs without any change in the sequence. Several approaches showed the role of epigenetic modifications and its inhibitors in controlling fibrosis and cancer. Only limited reports are focused on understanding the epigenetic regulations of radiation-induced lung EMT.
Conclusion: The current review focused on recent findings regarding radiation-induced lung fibrosis and EMT, thus provides some information on important signaling pathways, its subsequent expression of genes and proteins involved in EMT. This review also discussed various inhibitors that could be used to treat EMT related diseases, i.e., fibrosis, cancer.
Export Options
About this article
Cite this article as:
Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators, Current Drug Targets 2018; 19 (10) . https://dx.doi.org/10.2174/1389450119666180207092234
DOI https://dx.doi.org/10.2174/1389450119666180207092234 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship
Current Medicinal Chemistry Antioxidant Vitamins and Cardiovascular Disease
Current Topics in Medicinal Chemistry IP6 (Inositol Hexaphosphate) as a Signaling Molecule
Current Signal Transduction Therapy Preclinical and Clinical Efficacy of the Bisphosphonate Ibandronate in Cancer Treatment
Current Clinical Pharmacology An Overview on the Development of New Potentially Active Camptothecin Analogs Against Cancer
Mini-Reviews in Medicinal Chemistry Autoantibody Profiles as Biomarkers for Response to Therapy and Early Detection of Cancer
Current Cancer Therapy Reviews Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology Role of Tyrosine Kinase Inhibitors in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Anti-Carcinogenic Effects of Carnosol-An Updated Review
Current Drug Discovery Technologies Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences Cancer and the Endogenous “Pineal Clock”: A Means of Early Diagnosis and Successful Treatment as Well as Prevention of Cancers
Current Aging Science Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Cytotoxic Nitrobenzoyloxy-substituted Sesquiterpenes from Spongederived Endozoic Fungus Aspergillus insulicola MD10-2
Current Pharmaceutical Biotechnology Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening
Current Pharmaceutical Design Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Current Cancer Drug Targets E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Synthesis and Antiproliferative Assay of Norcantharidin Derivatives in Cancer Cells
Medicinal Chemistry Gene Therapy for the Peripheral Nervous System: A Strategy to Repair the Injured Nerve?
Current Gene Therapy